Year To Quarter End Consolidated Statement Of Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7328356

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
56,016,000,000 JPY
226,000,000 JPY
-64,000,000 JPY
62,843,000,000 JPY
62,907,000,000 JPY
6,664,000,000 JPY
6,660,000,000 JPY
53,579,000,000 JPY
298,000,000 JPY
60,538,000,000 JPY
-77,000,000 JPY
60,461,000,000 JPY
Cost of sales
32,178,000,000 JPY
31,876,000,000 JPY
Gross profit (loss)
30,664,000,000 JPY
28,584,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
24,164,000,000 JPY
23,476,000,000 JPY
Operating profit (loss)
7,647,000,000 JPY
-125,000,000 JPY
-1,216,000,000 JPY
2,499,000,000 JPY
6,500,000,000 JPY
7,717,000,000 JPY
195,000,000 JPY
409,000,000 JPY
5,779,000,000 JPY
658,000,000 JPY
-6,000,000 JPY
6,181,000,000 JPY
-1,073,000,000 JPY
5,108,000,000 JPY
Non-operating income
Interest income
4,000,000 JPY
0 JPY
Dividend income
330,000,000 JPY
338,000,000 JPY
Non-operating income
6,000,000 JPY
414,000,000 JPY
3,000,000 JPY
433,000,000 JPY
Non-operating expenses
Interest expenses
3,000,000 JPY
40,000,000 JPY
3,000,000 JPY
50,000,000 JPY
Share of loss of entities accounted for using equity method
41,000,000 JPY
19,000,000 JPY
Non-operating expenses
38,000,000 JPY
392,000,000 JPY
58,000,000 JPY
308,000,000 JPY
Ordinary profit (loss)
2,467,000,000 JPY
6,522,000,000 JPY
603,000,000 JPY
5,232,000,000 JPY
Extraordinary income
Extraordinary income
3,340,000,000 JPY
124,000,000 JPY
Profit (loss) before income taxes
2,467,000,000 JPY
9,862,000,000 JPY
603,000,000 JPY
5,357,000,000 JPY
Income taxes - current
3,000,000 JPY
3,514,000,000 JPY
39,000,000 JPY
1,108,000,000 JPY
Income taxes - deferred
-2,000,000 JPY
-1,197,000,000 JPY
-27,000,000 JPY
10,000,000 JPY
Income taxes
1,000,000 JPY
2,316,000,000 JPY
11,000,000 JPY
1,118,000,000 JPY
Profit (loss)
2,466,000,000 JPY
2,466,000,000 JPY
2,466,000,000 JPY
7,545,000,000 JPY
2,466,000,000 JPY
591,000,000 JPY
591,000,000 JPY
591,000,000 JPY
591,000,000 JPY
4,238,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
7,545,000,000 JPY
7,545,000,000 JPY
7,545,000,000 JPY
4,238,000,000 JPY
4,238,000,000 JPY
4,238,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
202,000,000 JPY
1,371,000,000 JPY
Remeasurements of defined benefit plans, net of tax
362,000,000 JPY
144,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
16,000,000 JPY
229,000,000 JPY
Other comprehensive income
581,000,000 JPY
1,745,000,000 JPY
Comprehensive income
8,127,000,000 JPY
5,983,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
8,127,000,000 JPY
5,983,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.